Companies/Treace Medical Concepts, Inc.

Company profile

Treace Medical Concepts, Inc.

NASDAQ: TMCI · Healthcare · Medical - Devices

PublicHQ Ponte Vedra, FLCIK 0001630627Reports USD

#283 of 1,394 Healthcare companies by revenue45th-percentile growth

EA Score

55C

FH 55DQ 52GM 59SS 57

v0.1 · 65/100 weight · provisional

↑ workforce scale, filing timeliness · ↓ listing tenure, disclosure history

Methodology →

Revenue TTM

$207.3M

Rev growth YoY (TTM)

-1.7%

Net income (FY)

-$59.0M

Employees

432

Market cap

$273.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$212.7M$212.7M2025

Net income-$59.0M-$59.0M2025

Operating income-$54.2M-$54.2M2025

Total assets$190.6M$190.6M2025

Liabilities$103.2M$103.2M2025

Equity$87.3M$87.3M2025

Revenue trend

FY2021 – FY2025 · USD

$39.4M

FY21

$57.4M

FY21

$94.4M

FY21

$141.8M

FY22

$187.1M

FY23

$209.4M

FY24

$212.7M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Treace Medical Concepts, Inc. booked $212.7M in FY2025 revenue, growing 1.6% year over year — about the middle of the pack among Healthcare companies we track, at a -27.7% net margin.

Peers · Healthcare

Niagen Bioscience Inc78B+Frontage Holdings Corporation72B Accendra Health, Inc.62C SIGA Technologies, Inc.73B

Key facts

CEOJohn T. Treace

SectorHealthcare

IndustryMedical - Devices

HeadquartersPonte Vedra, FL

ExchangeNASDAQ: TMCI

Employees432

IPO date2021-04-23

Latest filings

8-K2026-05-20 8-K2026-05-08 10-Q2026-05-08 8-K2026-04-09 DEF 14A2026-04-06 8-K2026-02-27 10-K2026-02-27 8-K2026-01-13

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.